Non Hodgkin Lymphoma News and Research

RSS
Researchers identify long-sought enzyme that prevents cancer

Researchers identify long-sought enzyme that prevents cancer

SwRI researchers part of two collaborative teams receive SAMF bioscience grants

SwRI researchers part of two collaborative teams receive SAMF bioscience grants

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

ADC histogram analysis can predict tumor proliferation, survival in immunocompetent patients with PCNSL

NCCN publishes new informational resources on health and wellness for cancer survivors

NCCN publishes new informational resources on health and wellness for cancer survivors

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Researchers evaluate safety of novel therapy for patients with non-Hodgkin lymphoma

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Testing for tumor DNA can help predict risk of relapse after transplant in DLBCL patients

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Clinical investigators present abstracts on hematological malignancies at ASH Annual Meeting and Exposition

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

Study: CAR T-cell therapy reduced cancer cells in patients with advanced non-Hodgkin lymphoma

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

More than 40 Dana-Farber studies to be presented at the virtual 62nd ASH Annual Meeting

Study finds increasing incidence of cancer among adolescents and young adults

Study finds increasing incidence of cancer among adolescents and young adults

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Radiation therapy before CART-BCMA appears to be a safe option for multiple myeloma patients

Study uses a statistical approach to reveal patterns of cancer incidence

Study uses a statistical approach to reveal patterns of cancer incidence

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

Scientists identify genetic link to predict treatment response in patients with aggressive blood cancer

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

FDA approves first CAR T-cell therapy for patients with mantle cell lymphoma

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

AI Therapeutics announces start of Phase II clinical trial of potential COVID-19 treatment

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval

First CAR T-cell therapy for mantle cell lymphoma receives FDA approval